Axiom Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Axiom Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $29,573 - $32,997	108 New	108 $30,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $32,435 - $38,250	-173 Closed	0 $0
Q1 2021 May 20, 2021	SELL	$207.02 - $241.31 $207,020 - $241,310	-1,000 Reduced 85.25%	173 $36,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $242,834 - $283,056	1,173 New	1,173 $250,000
Q3 2019 Mar 16, 2021	SELL	$166.23 - $187.09 $228,233 - $256,874	-1,373 Closed	0 $0
Q2 2019 Mar 16, 2021	BUY	$164.61 - $190.37 $226,009 - $261,378	1,373 New	1,373 $251,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Axiom Investment Management LLC with notifications on news.